Ignite Creation Date:
2025-12-25 @ 2:16 AM
Ignite Modification Date:
2025-12-27 @ 1:43 PM
Study NCT ID:
NCT01305460
Status:
COMPLETED
Last Update Posted:
2021-12-28
First Post:
2011-02-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Intensified Azacitidine in High Risk Myelodysplastic Syndrome (MDS)
Sponsor:
Groupe Francophone des Myelodysplasies
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-07-05
Start Date Type:
ACTUAL
Primary Completion Date:
2011-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-11-16
Completion Date Type:
ACTUAL
First Submit Date:
2011-02-25
First Submit QC Date:
None
Study First Post Date:
2011-02-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-12-24
Last Update Post Date:
2021-12-28
Last Update Post Date Type:
ACTUAL